These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20506078)

  • 1. Exocarpic acid inhibits mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Koch M; Bugni TS; Sondossi M; Ireland CM; Barrows LR
    Planta Med; 2010 Oct; 76(15):1678-82. PubMed ID: 20506078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial activity of Exocarpos latifolius is due to exocarpic acid.
    Koch M; Bugni TS; Pond CD; Sondossi M; Dindi M; Piskaut P; Ireland CM; Barrows LR
    Planta Med; 2009 Oct; 75(12):1326-30. PubMed ID: 19444772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
    Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
    J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
    Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
    Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].
    Luo H; Pang L; Xie J
    Wei Sheng Wu Xue Bao; 2012 Feb; 52(2):146-51. PubMed ID: 22586991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
    Alahari A; Alibaud L; Trivelli X; Gupta R; Lamichhane G; Reynolds RC; Bishai WR; Guerardel Y; Kremer L
    Mol Microbiol; 2009 Mar; 71(5):1263-77. PubMed ID: 19183278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2-alkynoic acids.
    Morbidoni HR; Vilchèze C; Kremer L; Bittman R; Sacchettini JC; Jacobs WR
    Chem Biol; 2006 Mar; 13(3):297-307. PubMed ID: 16638535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-mycobacterial diynes from the Canadian medicinal plant Aralia nudicaulis.
    Li H; O'Neill T; Webster D; Johnson JA; Gray CA
    J Ethnopharmacol; 2012 Mar; 140(1):141-4. PubMed ID: 22234257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
    Belardinelli JM; Morbidoni HR
    Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of ursolic acid on the inhibition of Mycobacterium tuberculosis and its cell wall mycolic acid.
    Jyoti MA; Zerin T; Kim TH; Hwang TS; Jang WS; Nam KW; Song HY
    Pulm Pharmacol Ther; 2015 Aug; 33():17-24. PubMed ID: 26021818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
    Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Canadian medicinal plant Heracleum maximum contains antimycobacterial diynes and furanocoumarins.
    O'Neill T; Johnson JA; Webster D; Gray CA
    J Ethnopharmacol; 2013 May; 147(1):232-7. PubMed ID: 23501157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the inhibitory activity of (aza)isoindolinone-type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis.
    Chollet A; Stigliani JL; Pasca MR; Mori G; Lherbet C; Constant P; Quémard A; Bernadou J; Pratviel G; Bernardes-Génisson V
    Chem Biol Drug Des; 2016 Nov; 88(5):740-755. PubMed ID: 27301022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycobacterial and antiplasmodial unsaturated carboxylic acid from the twigs of Scleropyrum wallichianum.
    Suksamrarn A; Buaprom M; Udtip S; Nuntawong N; Haritakun R; Kanokmedhakul S
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1327-9. PubMed ID: 16204994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A piperidinol-containing molecule is active against
    Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
    J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
    Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis.
    Léger M; Gavalda S; Guillet V; van der Rest B; Slama N; Montrozier H; Mourey L; Quémard A; Daffé M; Marrakchi H
    Chem Biol; 2009 May; 16(5):510-9. PubMed ID: 19477415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition.
    Li H; Cowie A; Johnson JA; Webster D; Martyniuk CJ; Gray CA
    BMC Genomics; 2016 Aug; 17(1):621. PubMed ID: 27514659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.
    Belardinelli JM; Morbidoni HR
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):429-40. PubMed ID: 23566152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis.
    Lehmann J; Cheng TY; Aggarwal A; Park AS; Zeiler E; Raju RM; Akopian T; Kandror O; Sacchettini JC; Moody DB; Rubin EJ; Sieber SA
    Angew Chem Int Ed Engl; 2018 Jan; 57(1):348-353. PubMed ID: 29067779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.